Advancing academia-driven treatment optimisation in oncology: Launch of the EMA Cancer Medicines Forum
- PMID: 35462319
- DOI: 10.1016/j.ejca.2022.03.025
Advancing academia-driven treatment optimisation in oncology: Launch of the EMA Cancer Medicines Forum
Conflict of interest statement
Conflict of interest statement The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
